Month: September 2020

Sep 29 2020

Uncategorized

Alkermes: Schizophrenia Drug Producer Taking Market Share, 5.5% 3-Month Upside

by Clinical Editor

No Comments

Alkermes plc is a global biopharmaceutical company focused on developing and commercializing products related to schizophrenia, bipolar disorder, multiple sclerosis, and recently oncology.

Sep 28 2020

Uncategorized

Researchers reveal sex differences in association between symptoms of schizophrenia and superoxide dismutase

by Clinical Editor

No Comments

Schizophrenia is a disabling psychiatric disorder characterized by positive symptoms, such as hallucinations and delusions, negative symptoms, such as decreased expression ability, and cognitive …

Sep 28 2020

Uncategorized

NIH public-private partnership to advance early interventions for schizophrenia

by Clinical Editor

No Comments

Effort is part of the Accelerating Medicines Partnership to promote development of effective, targeted treatments.

Sep 28 2020

Uncategorized

Schizophrenia and Bipolar I Disorder Combination Treatment Associated With Less Weight Gain

by Clinical Editor

No Comments

2 “The publication of the ENLIGHTEN-2 data in a peer-reviewed journal represents an important milestone for the ALKS 3831 development program and demonstrates Alkermes’ dedication to expanding the …

Sep 28 2020

Uncategorized

No charges recommended against police who fatally shot B.C. man with schizophrenia

by Clinical Editor

No Comments

An independent investigation into the death of a man suffering from schizophrenia who was shot by police in Maple Ridge, B.C., has recommended no charges against the officers involved. The...

Sep 28 2020

Uncategorized

NIH to promote early intervention for schizophrenia via public-private partnership

by Clinical Editor

No Comments

The National Institutes of Health announced a new public-private partnership, the goal of which is to meet the urgent need for early therapeutic interventions for people at risk of developing...

Sep 27 2020

Uncategorized

No charges recommended against police who fatally shot B.C. man with schizophrenia

by Clinical Editor

No Comments

An independent investigation into the death of a man suffering from schizophrenia who was shot by police in Maple Ridge, B.C., has recommended no charges against the officers involved. The...

Sep 27 2020

Uncategorized

Schizophrenia and Bipolar I Disorder Combination Treatment Associated With Less Weight Gain

by Clinical Editor

No Comments

2 “The publication of the ENLIGHTEN-2 data in a peer-reviewed journal represents an important milestone for the ALKS 3831 development program and demonstrates Alkermes’ dedication to expanding the …

Sep 27 2020

Uncategorized

Researchers reveal sex differences in association between symptoms of schizophrenia and superoxide dismutase

by Clinical Editor

No Comments

Schizophrenia is a disabling psychiatric disorder characterized by positive symptoms, such as hallucinations and delusions, negative symptoms, such as decreased expression ability, and cognitive …

Sep 27 2020

Uncategorized

Trending News: Schizophrenia Therapeutic Market Growth, Size, Analysis and Trends to 2026| Eli Lilly, Johnson and Johnson, Pfizer

by Clinical Editor

No Comments

Schizophrenia Therapeutic Market is expected to grow significantly over next few years and generate considerable market for Schizophrenia Therapeutic . Market Report Expert has recently published a …